Can confirm — identical experience.

As a healthcare provider, I want to add some clinical context to this discussion on NNC0519-0396 Novo next-gen oral GLP-1 .

Building on what jason_paloalto said — the evidence base here is well-established. The key publications to reference are from the STEP program[1].

Key clinical points:

1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
2. Side effect profile is predictable and usually manageable with standard protocols
3. Monitoring should include baseline labs and follow-up at 3-month intervals
4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

Reading this thread on NNC0519-0396 Novo hits close to home. Night shift nurse — I started at 271 lbs and felt like I would tried everything.

7 months on tirz and I am a different person. Not just the 46 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about NNC0519-0396 Novo — take the leap. It was the best health decision I have ever made. ❤️

lisa_labSD — that is really helpful context on NNC0519-0396 Novo. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

To answer BariatricNurseD's question specifically:

From a clinical standpoint, NNC0519-0396 Novo next-gen is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.